In this study, Rt.MCAO led to a marked reduction in hippocampal SOD, CAT, and GSH-Px levels, reflecting a compromised antioxidant defense system, which aligns with previous findings highlighting the overproduction of ROS during cerebral ischemia [47,48]. The gene discussed is SOD1; the disease is brain ischemia.